atomoxetine hydrochloride has been researched along with Recrudescence in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamzeh, R; Raj, SR; Sandhu, RK; Sheldon, RS | 1 |
| Bushe, C; Dittmann, RW; Escobar, R; Greenhill, LL; Heinloth, AN; Lipsius, S; Tanaka, Y; Thome, J; Upadhyaya, H | 1 |
| Alén, F; Antón, M; de Heras, RG; Gorriti, MÁ; Orio, L; Pavón, FJ; Pozo, MÁ; Ramírez-López, MT; Rodríguez de Fonseca, F; Serrano, A | 1 |
| Broos, N; De Vries, TJ; Loonstra, R; Pattij, T; Schetters, D; Schoffelmeer, AN; van Mourik, Y | 1 |
| Corbit, LH; Furlong, TM; Pan, MJ | 1 |
| Adler, LA; Amsterdam, JD; Dunner, DL; Michelson, D; Nierenberg, AA; Reimherr, FW; Schatzberg, AF; Williams, D | 1 |
| Adler, L; Allen, AJ; Brown, WJ; Heiligenstein, J; Kelsey, D; Michelson, D; Milton, D; Ruff, D; Spencer, T; Wernicke, JF; West, SA | 1 |
| King, RA; Lee, TD; Lee, TS; Lombroso, PJ | 1 |
| Barton, J; Benn, D; Danckaerts, M; Hazell, P; Johnson, M; Ladikos, A; Michelson, D; Wolańczyk, T; Yoran-Hegesh, R; Zeiner, P; Zhang, S; Zuddas, A | 1 |
| Adli, M; Bauer, M; Burghardt, R; Pilhatsch, MK; Wandinger, KP | 1 |
4 trial(s) available for atomoxetine hydrochloride and Recrudescence
| Article | Year |
|---|---|
The Seventh Prevention of Syncope Trial (POST VII)-A randomized clinical trial of atomoxetine for the prevention of vasovagal syncope: Rationale and study design.
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; Double-Blind Method; Humans; Quality of Life; Recurrence; Syncope, Vasovagal | 2023 |
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Odds Ratio; Propylamines; Recurrence; Sertraline; Tachyphylaxis; Treatment Outcome | 2009 |
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Humans; Propylamines; Prospective Studies; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome; Withholding Treatment | 2004 |
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Double-Blind Method; Female; Humans; Male; Propylamines; Recurrence; Risk; Severity of Illness Index | 2006 |
6 other study(ies) available for atomoxetine hydrochloride and Recrudescence
| Article | Year |
|---|---|
Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Male; Middle Aged; Placebo Effect; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Young Adult | 2017 |
The administration of atomoxetine during alcohol deprivation induces a time-limited increase in alcohol consumption after relapse.
Topics: Adrenergic Uptake Inhibitors; Alcohol Drinking; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Ethanol; Locomotion; Male; Propylamines; Rats; Rats, Wistar; Recurrence; Self Administration | 2014 |
Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Delay Discounting; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Impulsive Behavior; Male; Random Allocation; Rats, Wistar; Recurrence; Reinforcement Schedule; Self Administration | 2015 |
The effects of compound stimulus extinction and inhibition of noradrenaline reuptake on the renewal of alcohol seeking.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Drinking Behavior; Ethanol; Extinction, Psychological; Inhibition, Psychological; Male; Rats; Rats, Wistar; Recurrence; Self Administration | 2015 |
Atomoxetine and tics in ADHD.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Humans; Male; Propylamines; Recurrence; Tics | 2004 |
Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Nortriptyline; Propylamines; Psychotic Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2006 |